Safety of Aprotinin in Congenital Heart Operations: Results from a Large Multicenter Database

These data suggest aprotinin is not associated with increased mortality or dialysis in children undergoing congenital heart operations and that further evaluation of aprotinin in this population could be undertaken without undue risk.